Skip to main navigation Skip to search Skip to main content

Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma

  • Yoon Jung Jang
  • , Eo Jin Kim
  • , Hyung Don Kim
  • , Kyu Pyo Kim
  • , Min Hee Ryu
  • , Sook Ryun Park
  • , Won Mook Choi
  • , Danbi Lee
  • , Jonggi Choi
  • , Ju Hyun Shim
  • , Kang Mo Kim
  • , Young Suk Lim
  • , Han Chu Lee
  • , Baek Yeol Ryoo
  • , Changhoon Yoo
  • University of Ulsan
  • Korea Institute of Radiological and Medical Sciences
  • Kangbuk Samsung Hospital

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry